What is the size of the Global Biliary Stents Market in 2026?

The global biliary stents market was valued at approximately USD 915.4million in 2026. This valuation reflects total revenue generated across all stent types including self-expandable metal stents, plastic stents, covered metal stents, and emerging biodegradable variants, across all geographies and end-user settings including hospitals, ambulatory surgical centres, and specialty clinics. North America contributed the largest regional share at approximately 38 percent of the global total, reflecting the combination of high procedural volume, favourable reimbursement, and strong premium SEMS adoption rates in the U.S. market.

What is the CAGR of the Biliary Stents Market from 2026 to 2036?

The global biliary stents market is projected to grow at a compound annual growth rate of 7.1 percent from 2026 to 2036. This growth rate reflects the underlying demand expansion driven by rising biliary cancer incidence, geographic expansion of ERCP procedural capability, technology-driven migration from plastic to metal stents, and the emergence of new stent categories including biodegradable and drug-eluting variants. Asia Pacific is expected to exceed this global average at a regional CAGR of approximately 9.4 percent, driven by China, India, and Southeast Asian market growth.

Which region dominates the Global Biliary Stents Market and why?

North America dominates the global biliary stents market with approximately 38 percent of total 2026 revenue. Regional leadership is sustained by the combination of a high incidence of pancreatic and biliary cancers in an aging population, comprehensive insurance reimbursement coverage for ERCP with metal stent placement under both Medicare and commercial payors, strong institutional adoption of clinical guidelines recommending covered SEMS for malignant obstruction, and an advanced healthcare delivery infrastructure concentrated in major academic medical centres and rapidly growing ambulatory surgical centres. The U.S. also serves as the primary market for novel stent technology launches, giving early-adopting manufacturers revenue momentum before products reach global markets.

Which segment leads the Biliary Stents Market by type?

Self-expandable metal stents lead the biliary stents market by type with approximately 42 percent share of total 2026 revenue, a position that is expected to strengthen modestly through 2036. SEMS dominance reflects their established clinical superiority over plastic stents in patency duration and re-intervention rate for malignant biliary obstruction, which accounts for the largest share of total procedural volume. The covered SEMS sub-variant is the fastest-growing metal stent type at approximately 7.9 percent CAGR, while the biodegradable segment, though currently small at 4 percent share, is the fastest-growing type overall at 13.2 percent CAGR.

Which application segment is dominant in the Biliary Stents Market?

Malignant biliary obstruction is the dominant application segment with approximately 48 percent of total 2026 market revenue, equivalent to approximately USD 361 million. This dominance reflects the high prevalence of biliary obstruction as a complication of pancreatic head cancer, cholangiocarcinoma, and ampullary carcinoma, combined with the clinical imperative for stent placement as palliative treatment or as a bridge to chemotherapy in neoadjuvant protocols. The malignant obstruction segment is growing at approximately 7.6 percent CAGR, supported by rising cancer incidence and expanding adoption of neoadjuvant chemotherapy regimens that require pre-treatment biliary decompression.

Who are the key players in the Biliary Stents Market?

The global biliary stents market features more than 20 active commercial participants. The five leading players by global revenue are Boston Scientific Corporation, Cook Medical, Medtronic plc, Olympus Corporation, and Taewoong Medical. Other significant market participants include M.I. Tech, GORE Medical, ELLA-CS, Leufen Medical, Micro-Tech Nanjing, BD, EndoChoice (Fujifilm), Abbott Laboratories, Hobbs Medical, Piolax Medical Devices, Endo-Flex GmbH, Cantel Medical, Diagmed Healthcare, Conmed Corporation, and TaeWoong-USA. The market is moderately consolidated at the top and fragmented in regional and niche segments.

Biliary Stents Market Size Hit $2.05 Billion at 8.4% CAGR

Biliary Stents Market: Industry Analysis and Forecast 2026–2036

SPEAK TO AN ANALYST

SCHEDULE A DIRECT CONSULTATION WITH OUR INDUSTRY EXPERTS TO DISCUSS YOUR SPECIFIC REQUIREMENTS

Have specific questions about the market data or need strategic guidance?

7712

8 OUT OF TOP 10 Biliary Stents COMPANIES RELY ON MARKET BUSINESS INSIGHTS FOR THEIR GROWTH

By clicking the "Schedule Call" button, you are agreeing to the Terms of Use and Privacy Policy.

SPEAK TO AN ANALYST

FREE SAMPLE REPORT PAGES